Genetic Analysis of Hereditary Disorders of Hearing and Balance
NCT00023049
Deafness, Ear Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT Number: NCT07297355
The aim of this international study is to better understand how vestibular disorders affect daily life, including physical balance, vision and movement tolerance, emotional wellbeing, and cognitive functioning. Vestibular disorders are common but often difficult to diagnose because symptoms vary widely from one patient to another. To improve clinical care, we need large-scale information on the real-world experience of patients across different countries and clinical settings.
The UCLouvain Vertigo International Survey (UVIS) collects standardized information from adults with confirmed vestibular disorders, including questionnaires about dizziness-related handicap, emotional symptoms, and cognitive-vestibular complaints. Ear-nose-throat (ENT) specialists also provide routine clinical test results, such as caloric testing, vestibular evoked myogenic potentials (cVEMP and oVEMP), video head impulse tests (vHIT), and posturography. By combining these data, the study aims to identify different patient profiles and to examine how subjective symptoms relate to the physiological function of the vestibular system.
Participants take part during their routine clinical visit. They complete short questionnaires (on dizziness, anxiety, depression, cognitive symptoms, and daily functioning), and their ENT specialist encodes the results of the vestibular tests already performed as part of their usual care. No additional medical tests are required for the study.
By comparing data from several centers in Belgium, France, and the United States, this project seeks to provide a more complete picture of vestibular disorders worldwide and to support the development of better diagnostic tools and more personalized rehabilitation strategies.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Cliniques universitaires Saint-Luc, Brussels, Belgium
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
For patients :
Inclusion criteria
Exclusion criteria
For healthy controls :
Inclusion criteria
Exclusion criteria
Time frame: Through the entire study, approximately 36 months.
DHI - Dizziness Handicap Inventory (25 items; physical, functional, emotional subscales). Scores 0-100. Higher scores = greater handicap.
Time frame: Through the entire study, approximately 36 months.
HADS - Hospital Anxiety and Depression Scale (14 items; Anxiety and Depression subscales). Scores 0-21 per subscale. Higher scores = more symptoms
Time frame: Through the entire study, approximately 36 months.
NVI - Neuropsychological Vertigo Inventory (22 items assessing cognitive-vestibular symptoms: attention, memory, spatial orientation, visuospatial abilities). Higher scores = more complaints
Time frame: Through the entire study, approximately 36 months.
Time frame: Through the entire study, approximately 36 months.
Time frame: Through the entire study, approximately 36 months.
Time frame: Through the entire study, approximately 36 months.
Université Catholique de Louvain
Other
UVIS - UCLouvain Vertigo International Survey
Acronym: UVIS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00023049
Deafness, Ear Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06936345
BPPV, Ear Diseases
Istanbul, Beykoz, Turkey (Türkiye)
View Trial DetailsNCT06739577
Ear Diseases, Labyrinth Diseases
Brussels, Belgium
View Trial DetailsNCT04241822
Ear Diseases, Labyrinth Diseases
Bergen, Norway
View Trial Details